Ciraparantag for enoxaparin reversal: Adding to the evidence

Thromb Res. 2016 Oct:146:106-107. doi: 10.1016/j.thromres.2016.08.013. Epub 2016 Aug 13.

Authors

Jeffrey I Weitz¹, John W Eikelboom²

Affiliations

¹ McMaster University, Canada; Thrombosis and Atherosclerosis Research Institute, Canada. Electronic address: weitzj@taari.ca.
² McMaster University, Canada; Thrombosis and Atherosclerosis Research Institute, Canada; Population Health Research Institute, Canada.

PMID: 27544033
DOI: 10.1016/j.thromres.2016.08.013

No abstract available

Publication types

Editorial

MeSH terms

Arginine / administration & dosage
Arginine / analogs & derivatives*
Arginine / therapeutic use
Enoxaparin / pharmacology*
Humans
Piperazines / administration & dosage
Piperazines / therapeutic use*

Substances

Enoxaparin
Piperazines
Arginine
PER977